Vertex Pharmaceuticals (VRTX) Operating Income (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted Operating Income of $1.2 billion for Q2 2026, up 9.56% on a QoQ basis from $1.1 billion in Q1 2026, and up 8.32% year-over-year from $1.2 billion in Q2 2025.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Operating Income (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals has reported Operating Income for 18 years, with the latest figure at $1.2 billion in Q2 2026.
- On a quarterly basis, Operating Income rose 8.32% year-over-year to $1.2 billion in Q2 2026; TTM through Jun 2026 was $4.8 billion, a 21.76% increase from a year earlier, with the FY2025 full-year figure at $4.2 billion, up 1891.88% from the prior year.
- Operating Income was $1.2 billion for Q2 2026 at Vertex Pharmaceuticals, up from $1.1 billion in the prior quarter.
- The five-year high for Operating Income was $1.2 billion in Q2 2026, with the low at -$3.5 billion in Q2 2024.
- Average Operating Income over 5 years is $803.6 million, with a median of $1.1 billion recorded in 2022.
- The sharpest annual moves came in 2022 and 2024: Operating Income jumped 3019.0% in 2022, then sank 442.43% in 2024.
- Over 5 years, Operating Income stood at $1.0 billion in 2022, then fell by 4.35% to $988.5 million in 2023, then gained by 3.79% to $1.0 billion in 2024, then increased by 17.53% to $1.2 billion in 2025, then increased by 3.4% to $1.2 billion in 2026.
- The last three Operating Income figures came in at $1.2 billion (Q2 2026), $1.1 billion (Q1 2026), and $1.2 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn | 360.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.25 Bn |
| Mar 31, 2026 | 1.14 Bn |
| Dec 31, 2025 | 1.21 Bn |
| Sep 30, 2025 | 1.19 Bn |
| Jun 30, 2025 | 1.15 Bn |
| Mar 31, 2025 | 630.10 Mn |
| Dec 31, 2024 | 1.03 Bn |
| Sep 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | -3.51 Bn |
| Mar 31, 2024 | 1.14 Bn |
| Dec 31, 2023 | 988.50 Mn |
| Sep 30, 2023 | 1.04 Bn |
| Jun 30, 2023 | 1.03 Bn |
| Mar 31, 2023 | 779.00 Mn |
| Dec 31, 2022 | 1.03 Bn |
| Sep 30, 2022 | 1.13 Bn |
| Jun 30, 2022 | 1.11 Bn |
| Mar 31, 2022 | 1.04 Bn |
| Dec 31, 2021 | 877.70 Mn |
| Sep 30, 2021 | 1.05 Bn |
API Access
Vertex Pharmaceuticals Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();